Justin Leong
CIK 1825782 · View on SEC EDGAR ↗
First SEC filing: Oct. 6, 2020 · Latest: Oct. 6, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 22, 2024 | RMD | S | 6,160 | $243.09 | $1,497,434 | 21,718 Direct | -22.10% | Disposed | -5.4% (price as of 2026-08-21) |
| Aug. 5, 2024 | RMD | S | 48,000 | $217.07 | $10,419,360 | 18,741 Direct | -71.92% | Disposed | 5.9% (price as of 2026-08-21) |
| Nov. 22, 2022 | RMD | S | 3,777 | $229.50 | $866,822 | 59,817 Direct | -5.94% | Disposed | 0.2% (price as of 2026-08-21) |
| Nov. 5, 2020 | RMD | S | 7,740 | $211.36 | $1,635,926 | 25,386 Direct | -23.37% | Disposed | 8.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 22, 2022 | RMD | ResMed Common Stock Options | ResMed Common Stock (15,000) | $57.76 | Nov. 16, 2023 | 15,000 | Disposed |
| Nov. 16, 2022 | RMD | ResMed Common Stock Options | ResMed Common Stock (9,973) | $224.58 | Nov. 16, 2029 | 9,973 | Acquired |
| Nov. 18, 2021 | RMD | ResMed Common Stock Options | ResMed Common Stock (8,134) | $263.16 | Nov. 18, 2028 | 8,134 | Acquired |
| Nov. 5, 2020 | RMD | ResMed Common Stock Options | ResMed Common Stock (7,740) | $57.76 | Nov. 16, 2023 | 7,740 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | — | — | — | — | — | — | — | — |
| 2024 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.